Fungal Infections Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
In humans, fungal infections occur when an invading fungus takes over an area of the body and is too much for the immune system to handle. In some cases, fungi that aren’t typically found on or inside the body can colonize it and cause an infection. Only a few of the fungi pathogenic for humans are sufficiently virulent to infect a healthy host. Most are relatively harmless unless they encounter an immunocompromised patient.
The Fungal Infections marketed and pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, pricing and reimbursement, late-to-mid-stage pipeline products with phase transition success rate (PTSR), and the likelihood of approval (LoA) for fungal infections (FI). Moreover, it analyzes the clinical and commercial landscapes of FI, as well as an assessment of deals, future market catalysts, key market players, and the future competitive environment.
Key Mechanisms of Action of the Fungal Infections Marketed Drugs
The key mechanisms of action of the Fungal Infections marketed drugs are enzyme inhibitor, receptor agonist, and receptor antagonist.
Fungal Infections Marketed Drugs Analysis by Mechanisms of Action
For more mechanism of action insights, download a free report sample
Key Routes of Administration in the Fungal Infections Marketed Drugs
The key routes of administration in the Fungal Infections marketed drugs are injections and oral.
Fungal Infections Marketed Drugs Overview by Routes of Administration
For more route of administration insights, download a free report sample
Key Mechanisms of Action of the Fungal Infections Pipeline Drugs Market
The key mechanisms of action of the Fungal Infections pipeline drugs market are enzyme inhibitor, cell and cell organelle disrupter, protein and peptide inhibitor, ligand inhibitor, genes, nucleic acids, and related components inhibitor, and receptor antagonist.
Fungal Infections Pipeline Drugs Analysis by Mechanisms of Action
For more mechanism of action insights, download a free report sample
Key Routes of Administration in the Fungal Infections Pipeline Drugs Market
The key routes of administration in the Fungal Infections pipeline drugs market are injections, topical, oral, inhalational, and suppository.
Fungal Infections Pipeline Drugs by Routes of Administration
For more route of administration insights, download a free report sample
Key Molecule Types in the Fungal Infections Pipeline Drugs Market
The key molecule types in the Fungal Infections pipeline drugs market are small molecule, biologic, and polymer.
Fungal Infections Pipeline Drugs by Molecule Types
For more molecule type insights, download a free report sample
Key Players in the Fungal Infections Marketed and Pipeline Drugs Market
Some of the key players in the Fungal Infections marketed and pipeline drugs market are Cidara, Regeneron, Asahi Kasei, Profem, Galephar, CSPC Pharmaceuticals, and Pulmocide.
Fungal Infections Marketed and Pipeline Drugs Market Report Overview
Key Mechanisms of Action (Marketed Drugs) | Enzyme Inhibitor, Receptor Agonist, and Receptor Antagonist |
Key Routes of Administration (Marketed Drugs) | Injections and Oral |
Key Mechanisms of Action (Pipeline Drugs) | Enzyme Inhibitor, Cell and Cell Organelle Disrupter, Protein and Peptide Inhibitor, Ligand Inhibitor, Genes, Nucleic Acids, and Related Components Inhibitor, and Receptor Antagonist |
Key Routes of Administration (Pipeline Drugs) | Injections, Topical, Oral, Inhalational, and Suppository |
Key Molecule Types (Pipeline Drugs) | Small Molecule, Biologic, and Polymer |
Key Players | Cidara, Regeneron, Asahi Kasei, Profem, Galephar, CSPC Pharmaceuticals, and Pulmocide |
Scope
Components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Molecule Type, and Route of Administration
- Pricing and Reimbursement Assessment
- Retail or Manufacturer Price of Products
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, and Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, and Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Fungal Infections market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Fungal Infections market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
What are the key mechanisms of action of the Fungal Infections marketed drugs?
The key mechanisms of action of the Fungal Infections marketed drugs are enzyme inhibitor, receptor agonist, and receptor antagonist.
-
What are the key routes of administration in the Fungal Infections marketed drugs?
The key routes of administration in the Fungal Infections marketed drugs are injections and oral.
-
What are the key mechanisms of action of the Fungal Infections pipeline drugs market?
The key mechanisms of action of the Fungal Infections pipeline drugs market are enzyme inhibitor, cell and cell organelle disrupter, protein and peptide inhibitor, ligand inhibitor, genes, nucleic acids, and related components inhibitor, and receptor antagonist.
-
What are the key routes of administration in the Fungal Infections pipeline drugs market?
The key routes of administration in the Fungal Infections pipeline drugs market are injections, topical, oral, inhalational, and suppository.
-
What are the key molecule types in the Fungal Infections pipeline drugs market?
The key molecule types in the Fungal Infections pipeline drugs market are small molecule, biologic, and polymer.
-
Who are the key players in the Fungal Infections marketed and pipeline drugs market?
Some of the key players in the Fungal Infections marketed and pipeline drugs market are Cidara, Regeneron, Asahi Kasei, Profem, Galephar, CSPC Pharmaceuticals, and Pulmocide.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.